000 00936 a2200265 4500
005 20250517011016.0
264 0 _c20150914
008 201509s 0 0 eng d
022 _a1744-764X
024 7 _a10.1517/14740338.2015.997206
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKaewpoowat, Quanhathai
245 0 0 _aTigecycline : a critical safety review.
_h[electronic resource]
260 _bExpert opinion on drug safety
_cFeb 2015
300 _a335-42 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAnti-Bacterial Agents
_xadverse effects
650 0 4 _aDrug Interactions
650 0 4 _aHumans
650 0 4 _aMinocycline
_xadverse effects
650 0 4 _aTigecycline
700 1 _aOstrosky-Zeichner, Luis
773 0 _tExpert opinion on drug safety
_gvol. 14
_gno. 2
_gp. 335-42
856 4 0 _uhttps://doi.org/10.1517/14740338.2015.997206
_zAvailable from publisher's website
999 _c24487568
_d24487568